BioBanking quarterly reports

BioBanking Funds are invested within TCorp’s Hour-Glass Investment Facilities in three investment options: Cash Facility, Medium Term Growth Facility and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.

31 March 2017

As at 31 March 2017, the total funds held within the Biobanking Trust Fund were $55,882,256.40. This includes funds in both T-Corp and Westpac.

For the quarter ending 31 March 2017, $66,000 was deposited into the fund, and $792,166.82 was withdrawn from the fund.

Investment performance for the quarter in each of the Investment Management Fund was as follows:

  • Cash Fund – returned 0.67% (annual performance 2.50% pa)
  • Medium Term Growth Fund – returned 1.42% (annual performance 6.65% pa)
  • Long Term Growth Fund – returned 2.24% (annual performance 12.54% pa).

For the quarter ending 31 March 2017, there was a net gain on investment of $897,000.26.

31 December 2016

As at 31 December 2016, the total funds held within the Biobanking Trust Fund were $55,711,422.97. This includes funds in both T-Corp and Westpac.

For the quarter ending 31 December 2016, $28,500 was deposited into the fund, and $1,733,855.96 was withdrawn from the fund.

Investment performance for the quarter in each of the Investment Management Fund was as follows:

  • Cash Fund – returned 0.47% (annual performance 2.46% pa)
  • Medium Term Growth Fund – returned 1.60% (annual performance 4.61% pa)
  • Long Term Growth Fund – returned 4.15% (annual performance 7.33% pa).

For the quarter ending 31 December 2016, there was a net gain on investment of $1,356,612.52.

30 September 2016

As at 30 September 2016, the total funds held within the Biobanking Trust Fund were $56,060,166.41. This includes funds in both T-Corp and Westpac.

For the quarter ending 30 September 2016, $5,101,754.33 was deposited into the fund, and $691,506.83 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.65% (annual performance 2.58% pa)
  • Medium Term Growth Facility – returned 1.58% (annual performance 4.39% pa)
  • Long Term Growth Facility – returned 2.73% (annual performance 5.79% pa).

For the quarter ending 30 September 2016, there was a net gain on investment of $897,508.32.

30 June 2016

As at 30 June 2016, the total funds held within the Biobanking Trust Fund were $50,752,410.59. This includes funds in both T-Corp and Westpac.

For the quarter ending 30 June 2016, $4,508,717.50 was deposited into the fund, and $383,101.86 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.69% (annual performance 2.48% pa)
  • Medium Term Growth Facility – returned 1.90% (annual performance 2.22% pa)
  • Long Term Growth Facility – returned 2.88% (annual performance 0.57% pa).

For the quarter ending 30 June 2016, there was a net gain on investment of $938,186.46.

31 March 2016

As at 31 March 2016, the total funds held within the Biobanking Trust Fund were $45,688,608.50. This includes funds in both T-Corp and Westpac.

For the quarter ending 31 March 2016, $624,861.00 was deposited into the fund, and $915,421.62 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.63% (annual performance 2.39% pa)
  • Medium Term Growth Facility – returned -0.52% (annual performance -0.64% pa)
  • Long Term Growth Facility – returned -2.50% (annual performance -4.21% pa).

For the quarter ending 31 March 2016, there was a net loss on investment of $483,135.69.

2015 Quarterly Reports

31 December 2015

As at 31 December 2015, the total funds held within the Biobanking Trust Fund were $46,462,304.80. This includes funds in both T-Corp and Westpac.

For the quarter ending 31 December 2015, $3,248,154.00 was deposited into the fund, and $833,944.51 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.59% (annual performance 2.47% pa)
  • Medium Term Growth Facility – returned 1.38% (annual performance 3.76% pa)
  • Long Term Growth Facility – returned 2.66% (annual performance 5.54% pa).

For the quarter ending 31 December 2015, there was a net return on investment of $737,470.74.

30 September 2015

As at 30 September 2015 the total funds held within the Biobanking Trust Fund were $43,310,624.57 (includes funds in T-Corp and Westpac).

For the quarter ending 30 September 2015 $1,167,762.33 was deposited into the fund and $1,093,142.87 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.55% (annual performance 2.57% pa)
  • Medium Term Growth Facility – returned -0.53% (annual performance 5.26% pa)
  • Long Term Growth Facility – returned -2.33% (annual performance 7.49% pa)

For the quarter ending 30 September 2015 there was a net loss on investment of $643,072.10.

30 June 2015

As at 30 June 2015 the total funds held within the Biobanking Trust Fund were $43,879,077.21 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 June 2015 $7,799,727.00 was deposited into the fund and $308,025.04 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.60% (annual performance 2.73% pa)
  • Medium Term Growth Facility – returned -0.95% (annual performance 7.37% pa)
  • Long Term Growth Facility – returned -2.02% (annual performance 12.68% pa)

For the quarter ending 30 June 2015 there was a net loss on investment of $428,863.71.

31 March 2015

As at 31 March 2015 the total funds held within the Biobanking Trust Fund were $36,816,238.96 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 March 2015 $2,449,382.00 was deposited into the fund and $155,217.60 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.71% (annual performance 2.86% pa)
  • Medium Term Growth Facility – returned 3.89% (annual performance 10.16% pa)
  • Long Term Growth Facility – returned 7.43% (annual performance 17.27% pa)

For the quarter ending 31 March 2015 there was a net return on investment of $1,675,803.19.

2014 Quarterly Reports

31 December 2014

As at 31 December 2014 the total funds held within the Biobanking Trust Fund were $32,846,271.37 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 December 2014 $279,999.00 was deposited into the fund and $1,078,854.06 was withdrawn from the fund. Investment performance for the quarter in each of the Hour Glass facilities was as follows:

  • Cash Facility – returned 0.69% (annual performance 2.85% pa)
  • Medium Term Growth Facility – returned 2.85% (annual performance 6.66% pa)
  • Long Term Growth Facility – returned 4.56% (annual performance 9.31% pa)

For the quarter ending 31 December 2014 there was a net return on investment of $1,027,130.76.

30 September 2014

As at 30 September 2014 the total funds held within the BioBanking Trust Fund were $32,617,995.67 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 September 2014 $2,247,204.04 was deposited into the fund and $1,093,557.67 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.71% (annual performance 2.85% pa)
  • Medium Term Growth Facility – returned 1.45% (annual performance 6.47% pa)
  • Long Term Growth Facility – returned 2.38% (annual performance 10.31% pa)

For the quarter ending 30 September 2014 there was a net return on investment of $454,947.69.

30 June 2014

As at 30 June 2014 the total funds held within the BioBanking Trust Fund were $31,009,401.59 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 June 2014 $7,562,995.70 was deposited into the fund and $92,883.99 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.73% (annual performance 2.92% pa)
  • Medium Term Growth Facility – returned 1.63% (annual performance 7.65% pa)
  • Long Term Growth Facility – returned 1.98% (annual performance 13.49% pa)

For the quarter ending 30 June 2014 there was a net return on investment of $365,873.19.

31 March 2014

As at 31 March 2014 the total funds held within the BioBanking Trust Fund were $23,173,416.69 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 March 2014 $660,329.00 was deposited into the fund and $156,320.84 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.70% (annual performance 2.97% pa)
  • Medium Term Growth Facility – returned 0.59% (annual performance 8.52% pa)
  • Long Term Growth Facility – returned 0.14% (annual performance 16.50% pa)

For the quarter ending 31 March 2014 there was a net return on investment of $104,338.71.

2013 Quarterly Reports

31 December 2013

As at 31 December 2013 the total funds held within the BioBanking Trust Fund were $22,565,069.80 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 September 2013 $1,731.219.00 was deposited into the fund and $452,947.09 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.69% (annual performance 3.12% pa)
  • Medium Term Growth Facility – returned 2.66% (annual performance 10.70% pa)
  • Long Term Growth Facility – returned 5.51% (annual performance 22.48% pa)

For the quarter ending 31 December 2013 there was a net return on investment of $687,191.41.

30 September 2013

As at 30 September 2013 the total funds held within the BioBanking Trust Fund were $20,599,606.49 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 September 2013 $3,400,405.67 was deposited into the fund and $795,583.91 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.77% (annual performance 3.38% pa)
  • Medium Term Growth Facility – returned 2.58% (annual performance 10.14% pa)
  • Long Term Growth Facility – returned 5.33% (annual performance 20.61% pa)

For the quarter ending 30 September 2013 there was a net return on investment of $422,745.03.

30 June 2013

As at 30 June 2013 the total funds held within the BioBanking Trust Fund were $17,572,039.70 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 June 2013 $8,391,965.33 was deposited into the fund and $184,269.81 was withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.78% (annual performance 3.69% pa)
  • Medium Term Growth Facility – returned 2.44% (annual performance 10.74% pa)
  • Long Term Growth Facility – returned 4.68% (annual performance 20.55% pa)

For the quarter ending 30 June 2013 there was a net return on investment of $316,361.40.

31 March 2013

As at 31 March 2013 the total funds held within the BioBanking Trust Fund were $9,047,982.78 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 March 2013 $665,417.02 was deposited into the fund and $140,510.91 withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.85% (annual performance 4.03% pa)
  • Medium Term Growth Facility – returned 2.61% (annual performance 8.46% pa)
  • Long Term Growth Facility – returned 5.28% (annual performance 12.35% pa)

For the quarter ending 31 March 2013 there was a net return on investment of $291,821.50.

2012 Quarterly Reports

31 December 2012

As at 31 December 2012 the total funds held within the BioBanking Trust Fund were $8,231,255.17 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 December 2012 $1,970,983.45 was deposited into the fund and $624,301.34 withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 0.94%
  • Medium Term Growth Facility – returned 2.14%
  • Long Term Growth Facility – returned 3.90%

For the quarter ending 31 December 2012 there was a net return on investment of $207,329.21.

30 September 2012

As at 30 September 2012 the total funds held within the BioBanking Trust Fund were $6,677,243.85 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 September 2012 $606,034.40 was deposited into the fund and $145,270.87 withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.07%
  • Medium Term Growth Facility – returned 3.14%
  • Long Term Growth Facility – returned 5.28%

For the quarter ending 30 September 2012 there was a net return on investment of $209,034.79

30 June 2012

As at 30 June 2012 the total funds held within the BioBanking Trust Fund were $6,007,445.53 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 June 2012 $3,849,711.60 was deposited into the fund and $277,899.60 withdrawn from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.11%
  • Medium Term Growth Facility – returned 0.34%
  • Long Term Growth Facility – returned (2.44)%

For the quarter ending 30 June 2012 there was a net investment loss of $36,285.68.

31 March 2012

As at 31 March 2012 the total funds held within the Biobanking Trust Fund were $2,471,919.21 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 March 2012 there were no deposits into the fund and no withdrawals from the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.22%
  • Medium Term Growth Facility – returned 3.94%
  • Long Term Growth Facility – returned 7.51%

For the quarter ending 31 March 2012 there was a net investment return of $106,786.37.

2011 and prior Quarterly Reports

31 December 2011

As at 31 December 2011 the total funds held within the BioBanking Trust Fund were $2,365,132.84 (includes funds in both T-Corp and Westpac).

For the quarter ending 31 December 2011 $17,844.65 was deposited into the fund. There was also a withdrawal of $38,272.52 from the fund to cover an anniversary management payment for one landowner.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.25%
  • Medium Term Growth Facility – returned 1.73%
  • Long Term Growth Facility – returned 1.88%

For the quarter ending 31 December 2011 there was a net investment return of $38,231.27.

30 September 2011

As at 30 September 2011 the total funds held within the BioBanking Trust Fund were $2,350,461.45 (includes funds in both T-Corp and Westpac).

For the quarter ending 30 September 2011 $772,668.60 was deposited into the fund.

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.22%
  • Medium Term Growth Facility – returned (1.71%)
  • Long Term Growth Facility – returned (7.11%)

For the quarter ending 30 September 2011 there was a net investment loss of $51,729.97.

30 June 2011

As at 30 June 2011 the total funds held within the BioBanking Trust Fund were $1,761,372.12 (includes funds in both T-Corp and Westpac).

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.31%
  • Medium Term Growth Facility – returned 0.36%
  • Long Term Growth Facility – returned (1.64%)

For the quarter ending 30 June 2011 there was a net investment loss of $962.11.

31 March 2011

As at 31 March 2011 the total funds held within the BioBanking Trust Fund were $1,432,267.92 (includes funds in both T-Corp and Westpac).

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility – returned 1.35%
  • Medium Term Growth Facility – returned 2.25%
  • Long Term Growth Facility – returned 3.18%

For the quarter ending 31 March 2011 there was a net investment return of $20,827.43.

For the quarter ending 31 March 2011 $888,403.00 was deposited into the fund.

31 December 2010

As at 31 December 2010 the total funds held within the BioBanking Trust Fund were $523,037.49 (includes funds in both T-Corp and Westpac).

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows: 

  • Cash Facility – returned 1.34%
  • Medium Term Growth Facility – returned 1.65%
  • Long Term Growth Facility – returned 2.62%

For the quarter ending 31 December 2010 there was a net investment return of $9,973.14.

30 September 2010

As at 30 September 2010 the total funds held within the BioBanking Trust Fund were $513,064.35 (includes funds in both T-Corp and Westpac).

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility - returned 1.26%
  • Medium Term Growth Facility - returned 2.71%
  • Long Term Growth Facility - returned 4.19%

For the quarter ending 30 September 2010 there was a net investment return of $14,184.08.

30 June 2010

As at 30 June 2010 the total funds held within the BioBanking Trust Fund were $498,880.27 (includes funds in both T-Corp and Westpac).

Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:

  • Cash Facility - returned 1.17%
  • Medium Term Growth Facility - returned 0.93%
  • Long Term Growth Facility - returned 4.83%

For the quarter ending 30 June 2010 there was a net investment loss of $2,748.73.

31 March 2010

No funds have been received into the BioBanking Trust Fund as at 31 March 2010.

31 December 2009

No funds have been received into the BioBanking Trust Fund as at 31 December 2009.

30 September 2009

No funds have been received into the BioBanking Trust Fund as at 30 September 2009.

30 June 2009

No funds have been received into the BioBanking Trust Fund as at 30 June 2009.

31 March 2009

No funds have been received into the BioBanking Trust Fund as at 31 March 2009.

31 December 2008

No funds have been received into the BioBanking Trust Fund as at 31 December 2008.

30 September 2008

No funds have been received into the Biobanking Trust Fund as at 30 September 2008.

Page last updated: 18 September 2017